Research
GE Healthcare opens Life Science Demonstration Lab
GE healthcare goes ahead with the launch of a new technology, known as GE Healthcare Life Sciences Demonstration Laboratory, at the Science for Life Laboratory (SciLifeLab) in Stockholm, Sweden.
UC Davis combines PET and MRI into one device
Scientists at the University of California, Davis have built the world
Functional MRI may lead to improved diagnosis of autism
Functional magnetic resonance imaging (fMRI) may provide an early and objective indicator of autism.
Unnecessary scanning pose health risk, says UVic study
Health consumers are largely naive about radiation and other risks that come with full-body and other screening tests marketed by private clinics, a University of Victoria health policy researcher says.
Non-infectious diseases become major health threat in China
Non-infectious chronic diseases have become the major threat to human health in China as deaths from such diseases account for 85 percent of annual total deaths in the country, a report warned.
Cancer expected to increase in Asian countries
People living in Asian countries are adopting bad western habits, which greatly increases the risk of Cancer. It is expected that the rate of cancer patients in Asia will reach 60 percent by 2020.
Tufts Summer Institute announces training on Web Strategies for Health Communication
Learn how you can help healthcare organizations develop and implement Web strategies to drive the success of their online presence.
Stem cells ‘allow paralysed man to breath again’
An Australian man paralysed from the neck down in a sporting accident 14 years ago has claimed he can breathe again unaided for the first time after having stem cell treatment in India. Perry Cross is the highest profile patient so far to claim success for the treatment offered by a medical centre in south Delhi which, if true, would represent a remarkable breakthrough.
Anesthesia market to reach $4 billion
The anesthesia, respiratory, and sleep management device market will reach approximately $4 billion by 2017.
Limiting gadolinium use may avert renal systemic fibrosis, says study
Following the adoption of restrictive guidelines for gadolinium-based contrast agent administration, no new nephrogenic systemic fibrosis cases have been identified in contrast-enhanced magnetic resonance examinations, even in patients with a low estimated glomerular filtration rate.
Mixing drugs causes adverse glucose effect in blood
A relatively common drug combination
Research for Nanotech in Bangalore by Wipro
Wipro, in collaboration with Belgian research institute IMEC is setting up a high-end nanotechnology R&D centre in Bangalore.
